Kałwik, M. et al. 2026. Anti-CD20 MONOCLONAL ANTIBODIES IN THE TREATMENT OF MULTIPLE SCLEROSIS: MECHANISMS OF ACTION, CLINICAL EFFICACY, SAFETY, AND CONTEMPORARY THERAPEUTIC PERSPECTIVES. International Journal of Innovative Technologies in Social Science. 4, 3(51) (Sep. 2026). DOI:https://doi.org/10.31435/ijitss.3(51).2026.6456.